Dr. Kathryn Macapagal, director of the Social Media Working Group at ISGMH and research assistant professor at Northwestern, has been selected by the NIH’s Office of AIDS Research as a 2018 Administrative Supplement Awardee. Dr. Macapagal received the grant for her research on adolescent men who have sex with men (AMSM)’s perspectives on novel biomedical HIV prevention approaches.
AMSM are disproportionately affected by HIV and account for 63.4% of new infections nationally among adolescents from 2010-2014. Daily oral pre-exposure prophylaxis (PrEP) is a highly effective, biomedical HIV prevention method that was recently FDA approved for adolescents in May 2018. Although PrEP has the potential to significantly curb infection rates among AMSM, its effectiveness has been impacted by the fact that many AMSM face individual and structural challenges with adherence to daily oral PrEP.
Dr. Macapagal’s project seeks to conduct an online, qualitative study to shed light on AMSM’s perspectives on event-driven, injectable, and implantable PrEP. Results will inform whether and how changes need to be made to the development and implementation of novel HIV prevention products to increase AMSM interest, uptake, and adherence when these products are approved for adolescent use.